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ABSTRACT
Integration is an essential step in the retroviral
lifecycle, and the lentiviral integrase binding protein
lens epithelium-derived growth factor (LEDGF)/p75
plays a crucial role during human immunodeficiency
virus type 1 (HIV-1) cDNA integration. In vitro,
LEDGF/p75 stimulates HIV-1 integrase activity into
naked target DNAs. Here, we demonstrate that
this chromatin-associated protein also stimulates
HIV-1 integration into reconstituted polynucleosome
templates. Activation of integration depended on
the LEDGF/p75-integrase interaction with either
type of template. A differential requirement for the
dominant DNA and chromatin-binding elements of
LEDGF/p75 was however observed when using
naked DNA versus polynucleosomes. With naked
DNA, the complete removal of these N-terminal
elements was required to abate cofactor function.
With polynucleosomes, activation mainly depended
on the PWWP domain, and to a lesser extent on
nearby AT-hook DNA-binding motifs. GST pull-
down assays furthermore revealed a role for the
PWWP domain in binding to nucleosomes. These
results are completely consistent with recent ex
vivo studies that characterized the PWWP and
integrase-binding domains of LEDGF/p75 as crucial
for restoring HIV-1 infection to LEDGF-depleted
cells. Our studies therefore establish novel in vitro
conditions, highlighting chromatinized DNA as
target acceptor templates, for physiologically
relevant studies of LEDGF/p75 in lentiviral cDNA
integration.
INTRODUCTION
HIV-1 infection proceeds through a series of ordered
events. Soon after entering a target cell, the viral enzyme
reverse transcriptase converts the viral RNA genome into
linear, double-stranded cDNA containing long terminal
repeats (LTRs). This cDNA is the substrate for the
enzyme integrase, which binds to U3 and U5 sequences at
the outer edges of the upstream and downstream LTRs,
respectively. Integrase possesses two enzyme activities,
known as 30 processing and DNA strand transfer, that
are essential for integration. Integrase hydrolyzes a
dinucleotide from each LTR end during the 30 processing
reaction. After entering the cell nucleus and locating an
eﬀective target DNA site, integrase uses the recessed
30-hydroxyl groups to cut the host DNA in a staggered
fashion, which at the same time joins the viral cDNA ends
to the resultant 50 overhangs. Repair of the single-stranded
gaps in the resulting DNA recombination intermediate,
which is likely accomplished by host DNA repair enzymes,
completes the integration process. See Ref. (1) for a recent
review on HIV-1 integration.
Puriﬁed recombinant integrase proteins possess 30
processing and DNA strand transfer activities (2–5).
Simpliﬁed forms of in vitro integration assays utilize a
synthetic LTR oligonucleotide for the donor DNA
substrate that is processed by integrase, and a second
LTR oligonucleotide as the target acceptor molecule into
which the processed DNA integrates (3,4). These naked
DNA substrates contrast sharply to the situation in vivo,
where both the viral and host DNAs exist as higher order
nucleoprotein complexes: integrase functions as part of a
large preintegration complex (PIC) that is derived from
the virion core (6), and the target DNA is ensconced
within chromatin.
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frequency and distribution of retroviral integration. For
example, HIV-1 and Moloney murine leukemia virus
(Mo-MLV) integrases favor the widening of the major
groove that occurs as the DNA wraps around the
nucleosome core (7–11). By contrast, these viruses target
chromatin quite diﬀerently on the genomic scale. HIV-1
preferentially integrates into active genes, fairy equally
along their lengths (12,13). Mo-MLV in contrast displays
much less preference for gene activity, yet targets regions
within 5kb of transcriptional start sites  25% of the time
(13–15). Analyses of HIV-1/Mo-MLV chimera viruses has
revealed integrase as the principle viral determinant
responsible for diﬀerential gene targeting during integra-
tion (16). The mechanism whereby Mo-MLV integrase
preferentially targets gene start sites is unknown. In
contrast, the propensity for HIV-1 to integrate fairly
equally along the lengths of active genes is in large part
governed by its interaction with the cellular chromatin-
associated protein lens epithelium-derived growth factor
(LEDGF)/p75 (15,17).
LEDGF/p75 can be thought of as a molecular tether
(18–22) and both its integrase and chromatin-binding
functions are critical for HIV-1 infection (15,23). LEDGF/
p75 binds to integrase via a conserved, C-terminally
located integrase-binding domain (IBD) that spans
residues 347–429 of the 530 residue human protein
(21,24). LEDGF/p75 mutants lacking the IBD, or
containing the substitution of asparigine for Asp-366
that abrogates the interaction with integrase in vitro (25)
and in yeast cells (26), fail to rescue the infection defect
accrued via LEDGF/p75 depletion (15,23). LEDGF/p75
interacts with chromatin utilizing conserved regions within
the N-terminal half of the protein including a PWWP
domain, nuclear localization signal (NLS), and a tandem
copy of the AT-hook DNA-binding motif (27,28).
Deletion mutants lacking the PWWP domain and AT-
hooks failed to rescue HIV-1 infection in LEDGF/p75-
depleted cells (15,23). As a deletion that lacked just the
PWWP domain functioned at  17% of the level of wild-
type LEDGF/p75 and a mutant lacking only the AT-
hooks displayed wild-type function, the PWWP domain
would appear to contribute the dominant chromatin-
binding function for HIV-1 integration (15). The mole-
cular mechanism of LEDGF/p75 chromatin binding is
currently unknown. One study indicated that the PWWP
domain directly bound to DNA (29), whereas a separate
study ascribed DNA binding to the NLS and AT-hooks,
inferring that the PWWP domain likely mediates interac-
tion(s) with protein components(s) of chromatin (27).
Puriﬁed LEDGF/p75 protein potently stimulates the 30
processing and DNA strand transfer activities of puriﬁed
HIV-1 integrase in vitro (30). Stimulation strictly depends
upon an intact IBD (24,25), but the N-terminal chromatin
and DNA-binding regions were in large part dispensable
for enzymatic stimulation (27). As these properties
contrasted with the crucial role of the N-terminal regions
during HIV-1 integration in vivo (15,23), we investigated if
this discrepancy depended upon the nature of the target
DNA template. By using chromatinized integration
templates, we have established an in vitro assay that
relies on the LEDGF/p75 PWWP domain for maximum
stimulation of integrase function. We therefore conclude
that future in vitro studies of LEDGF/p75’s role in HIV-1
integration will beneﬁt from utilizing nucleosome tem-
plates as targets for DNA strand transfer reactions.
MATERIALS AND METHODS
Reconstitution and purification of nucleosomal templates
The 2.56kb 5S-G5E4 fragment for polynucleosome (PN)
assembly was isolated from p2085S-G5E4 following
digestion with Asp718I and ClaI (31). The fragment was
labeled at the Asp718I end using [a-
32P]dATP and the
Klenow fragment of DNA polymerase. Products of DNase
I digestion were separated on a 1 % agarose native gel and
visualized using a phosphorImager and ImageQuant soft-
ware. Mononucleosomes (MNs) were assembled on a
PCR-ampliﬁed 157bp TPT fragment harboring a tandem
repeat of the 20bp GT phasing sequence (32). PN and MN
templates were assembled with puriﬁed HeLa core histones
(33) by gradient salt dialysis utilizing NaCl and KCl,
respectively (34,35).
Expression andpurification ofrecombinant proteins
Hexa-histidine (His6)-tagged HIV-1 integrase from the
NL4-3 strain was expressed in Escherichia coli and puriﬁed
by Ni-nitrilotriacetate chromatography in the absence of
detergent using 10mM ZnSO4 in the column elution buﬀer
as described (36).
The following His6-tag LEDGF/p75 fusion proteins
were expressed in E. coli, puriﬁed, and treated with
PreScission protease to remove the tags prior to integra-
tion assays as described (27): LEDGF
1–530 (wild-type),
LEDGF
MutL1 (containing six amino acid substitutions in
the NLS and six more in the AT-hooks), LEDGF
MutL7
(residues 93–530), LEDGF
MutL8 (LEDGF
MutL7 carrying
the 12 MutL1 substitutions), LEDGF
1-226 and
LEDGF
347–530. Untagged LEDGF
D366N was expressed
and puriﬁed as described (25). The following glutathione
S-transferase (GST) fusion proteins were expressed in
E. coli and puriﬁed as described (24): LEDGF
1–530,
LEDGF
1–325, LEDGF
326–530, LEDGF
1–471,
LEDGF
326–471 and LEDGF
347–471. The region of
LEDGF/p75 that lies between the PWWP domain and
AT-hooks is poorly conserved among orthologs and
highly susceptible to proteolysis (24), precluding the
removal of the GST tag via engineered thrombin sites
for a subset of proteins. As LEDGF
326–530 lacks this
region, the tag was removed from this protein by
thrombin cleavage prior to integration assays.
Plasmids encoding GST fused to LEDGF
93–471,
LEDGF
226–471 or LEDGF
1–100 were constructed in
pGEX-4T1 (GE Healthcare) as described (24), and
GST-LEDGF
226–471 and GST-LEDGF
1–100 were puriﬁed
from E. coli strain BL21 following induction of protein
expression with isopropyl-thio-b-galactopyranoside
(IPTG) at 378C essentially as previously described (24).
As GST-LEDGF
93–471 was unstable under these condi-
tions, it was isolated from 7L of E. coli strain XL1-Blue
grown at 288C to an optical density at 600nm of 3.0 in the
1238 Nucleic Acids Research, 2008, Vol. 36, No. 4absence of IPTG induction using a bench top fermentor.
GST-LEDGF
93–471 was then puriﬁed essentially as pre-
viously described (24).
In vitro integration assays
Assays were conducted in 50mM NaCl, 20mM HEPES–
HCl, pH 7.0, 4mM MgCl2,4mM ZnCl2, 100mg/ml bovine
serum albumin (BSA) and 1mM dithiothreitol (DTT).
In condition 1, mini-HIV donor DNA (16nM) mixed with
integrase (1mM) were pre-incubated for 10min at 48C
followed by 10min at 378C. LEDGF/p75 was added, and
mixtures were incubated for 10min at 378C prior to
adding naked DNA target or PN template to the ﬁnal
concentration of 5ng/ml (35nM equivalent of nucleosomes
for PN). Other chronologies of addition of reaction
components are summarized in Figure 2B. After 90min
at 378C, reactions were stopped by the addition of EDTA
and SDS to 25mM and 0.5%, respectively, and treated
with proteinase K (1mg/ml) for 45min at 558C. DNAs
recovered following precipitation with ethanol were used
as template for real-time quantitative PCR, using a three
primer design adapted from Ref. (27): AE2397; pT-For,
50-GCTGTGGAAGCGCTGTATGTTGTTC-30; pT-Rev,
50-GGCAGCCATAACAGTCAGCCTTACC-30. Each
integration sample was analyzed in duplicate by real-
time PCR, and each integration assay was repeated at
least three times.
GST pull-down assays
Assays were adapted from Ref. (24). Puriﬁed GST fusion
proteins were absorbed onto Glutathione-Sepharose
beads (GE Healthcare) in buﬀer 1 (200mM NaCl, 5mM
DTT, 25mM Tris–HCl, pH 8.0) using 50ml (settled
volume) of beads per 160pmol of protein. After 4h at
48C, beads were washed in excess volume of buﬀer 1 and
stored on ice. GST-LEDGF-containing beads (10ml
settled volume) resuspended in buﬀer 2 (50–250mM
NaCl as indicated, 5mM DTT, 25mM Tris–HCl, pH
8.0, 4mM MgCl2, 0.1% NP40, 100mg/ml BSA, 0.2mM
phenylmethysulfonyl ﬂuoride) were incubated with 800ng
of radiolabeled template DNA or assembled nucleosomes.
Samples gently rocked at 48C for 90min were left to stand
without mixing for an additional 30min. Beads washed
twice in excess volume of buﬀer 2 without BSA were
resuspended in a minimal volume of this buﬀer, and
portions were either separated by SDS–PAGE for western
blotting with anti-histone H3 antibody (Abcam Ab1791)
or digested with proteinase K as described above. DNAs
recovered following this treatment were fractionated
through native gels and detected by phosphorImager.
RESULTS AND DISCUSSION
Experimental strategy
To study the eﬀects of chromatin structure and LEDGF/
p75 protein on HIV-1 integrase activity, we established
an in vitro assay utilizing puriﬁed proteins, mini-HIV
donor DNA, and a linearized target DNA fragment
that was either left naked or complexed with nucleosomes.
The mini-HIV donor, linearized by digestion with ScaI,
harbors blunt ends corresponding to the unprocessed viral
cDNA ends (37) (Figure 1A). The 5S-G5E4 acceptor
fragment was chosen because it contains an array of
sequences that mandate nucleosome positioning, which,
upon nucleoprotein complex formation, yields a PN
(Figure 1B). This template has been used to study
chromatin remodeling, histone modiﬁcations and several
enzymatic processes occurring on chromatin in vitro
(38–40). The PN template was assembled by salt gradient
dialysis using native histones puriﬁed from Hela
cells and diﬀerent ratios of DNA/histone octamers.
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Figure 1. DNA substrates and nucleosome construction. (A) The mini-
HIV plasmid is linearized by digestion with ScaI (recognition sequence
in capital letters), which generates blunt ends corresponding to the
authentic unprocessed HIV-1 LTRs (shaded boxes). (B) The 5S-G5E4
acceptor template. Gray ovals, 5S rRNA positioned nucleosomes; black
ovals, two nucleosomes covering ﬁve Gal 4-binding sites and
adenovirus 2 E4 minimal promoter, which do not adopt deﬁned
positions; vertical arrows, EcoRI sites, with restriction fragment sizes
indicated. The relative positions of PCR primers used to quantify
integration activity are noted in panels A and B. (C) Electrophoretic
analysis of PN assembly. The starting template DNA (lane 2) and PN
templates assembled using the indicated mass ratios (mg/mg) of DNA/
histone (lanes 3–5) were digested with EcoRI and separated on a 0.8%
agarose gel. The migration positions of liberated 5S nucleosomes (Nuc)
and unliganded digestion products are indicated to the right of the
ethidium-stained gel; the positions of molecular mass standards are
indicated to the left. (D) Electrophoretic analysis of the MN. The
assembled MN template (lane 3) was visualized on a 5% polyacryla-
mide gel relative to the starting 157bp TPT DNA fragment (lane 2).
The positions of molecular mass standards are indicated to the left.
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following digestion with EcoRI, which cleaves the starting
DNA substrate into multiple 196bp 5S repeat fragments
and a central 431bp Gal 4-containing fragment
(Figure 1B and C).
Integration reactions were initiated by preincubating
integrase (1mM) and mini-HIV DNA (16nM) in a
magnesium-dependent reaction buﬀer at 48C for 10min,
followed by 10min at 378C. LEDGF/p75 was added, the
mixture was incubated at 378C for 10min, followed by
addition of PN template or corresponding DNA fragment
(35nM). DNA strand transfer was then allowed to
proceed for 90min at 378C. The integration products
were deproteinized and quantiﬁed by real-time PCR, using
one primer complementary to the U5 end of mini-HIV
(Figure 1A) and two centrally positioned, outward facing
primers complementary to the 5S-G5E4 fragment
(Figure 1B). This design monitors integration by quantify-
ing the extent of U5 DNA end joining (27) independent
of what may occur at the downstream U3 end. Single U3
end integration as well as products resulting from the
combined integration of both U3 and U5 ends are
expected to occur, but the formation of these products
was not monitored here. The extent of U5 end integration
provided a perfect quantitative platform to evaluate the
inﬂuence of PNs on LEDGF/p75-dependent HIV-1
integration in vitro.
LEDGF/p75 activates HIV-1 integrase activity
on naked DNA and PN acceptortemplates
In the absence of LEDGF/p75, integration into the
PN template was 12 times more eﬃcient than when
utilizing the corresponding naked DNA fragment
(Figure 2A, inset), a result consistent with previous studies
utilizing nucleosome cores (9). LEDGF/p75 stimulated
integration into both types of acceptor templates
(Figure 2A). The eﬃciency of integration into naked
DNA increased with increasing LEDGF/p75 concentra-
tion, up to the highest level tested (1.5mM). Stimulation of
integration into PNs in contrast was maximal at 500nM
LEDGF/p75. Accordingly, at this concentration and
below, integration was more eﬃcient using PNs than the
naked DNA template.
Various parameters contribute to the mechanism of
LEDGF/p75 stimulation of HIV-1 integrase activity
in vitro. Foremost is the protein–protein interaction
(24,25,41). The integrase-to-LEDGF/p75 ratio (42), as
well as the order by which individual components are
added into the reaction mixture (41,43), can also inﬂuence
product formation. In our initial experiment (Figure 2A
and B, condition 1), LEDGF/p75 was added to a
preformed integrase–mini-HIV donor complex before the
addition of the naked DNA or PN template. Due to the
propensity of LEDGF/p75 to bind up to three separate
components in these reaction mixtures (DNA, nucleo-
somes, integrase), four additional chronologies
(Figure 2B, conditions 2–5) were tested to gain insight
into the mechanism of LEDGF/p75 action.
Maximal levels of PN-dependent integration occurred
under conditions whereby integrase and LEDGF/p75
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Figure 2. LEDGF/p75-dependent stimulation of HIV-1 integrase
activity using naked DNA and PN acceptor templates.
(A) Integration eﬃciencies into naked DNA versus PNs. Integration
products obtained using the 5S-G5E4 fragment (DNA) or PNs in the
absence or presence of LEDGF/p75 (150nM, 500nM or 1.5mM) were
quantiﬁed by real-time PCR. Error bars represent the variation
obtained following duplicate PCRs of a minimum of three integration
assays. AU, arbitrary units. (B) Order of addition experiments.
Integration assays performed using naked DNA or PNs, in the absence
of presence of LEDGF/p75 (150 or 500nM) (top histogram). The
various components, integrase (IN), mini-HIV (Donor), LEDGF and
integration acceptor template, were added to the reaction mixtures
using the noted ﬁve diﬀerent chronologies (detailed in the bottom
diagram). (C) Eﬀect of LEDGF/p75 on DNase I accessibility of PN
templates. PNs were incubated for 15min at 378C with the indicated
levels of LEDGF/p75 prior to a 2min DNAse I digestion, performed
with following quantities of nuclease: 0U, 1, 10,1 00; 0.01U, 2, 20,2 00;
0.03U, 3, 30,3 00; 0.1U, 4, 40,4 00; 0.3U, 5, 50,5 00 and 1U, 6, 60,6 00.
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pathway (Figure 2B, conditions 1, 3 and 4); less
stimulation was observed when LEDGF/p75 was initially
prebound to PNs (condition 2) or to mini-HIV donor
DNA (condition 5). In contrast, integration into naked
DNA was most eﬃcient under condition 2, when
LEDGF/p75 was preincubated with the target DNA
prior to mixing with the integrase–mini-HIV complex. To
investigate whether the lower level of PN-dependent
integration under this condition was due to changes in
nucleoprotein structure that may have occurred during
LEDGF/p75 binding, the susceptibility of PNs to DNase I
digestion in the absence and presence of LEDGF/p75 was
examined (Figure 2C). LEDGF/p75 did not detectably
alter nucleosome positioning along the PN array, how-
ever, more DNase I was required to obtain the same
extent of digestion in the presence of LEDGF/p75 than in
its absence (compare lanes 4, 40 and 400). These results
indicate that LEDGF/p75 may preferentially bind to the
free linker DNA sequences that lie between the positioned
nucleosomes, but that binding did not induce gross
structural alterations within the PN template.
LEDGF/p75 regions importantforstimulating HIV-1
integration into nakedDNA versus PNs
We next investigated LEDGF/p75 domains and amino
acid residues important for stimulating HIV-1 integration
into naked DNA versus PN acceptor templates. Binding
to non-speciﬁc DNA in vitro is predominantly mediated
by the NLS and AT-hook DNA-binding motifs (27),
whereas the PWWP domain in concert with the AT-hooks
mediates the binding of the protein to chromatin in live
cells (27,28); charged regions (CRs) 1–3 located within
residues 93–325 also contribute to chromatin binding (28).
The IBD located within the C-terminal part of LEDGF/
p75 mediates the interaction with integrase (21,24); Asp-
366 within this domain is a key hotspot residue for the
interaction (25,26,44). Deletion or missense mutant
proteins altered at one or more of these functional
determinants (Figure 3A), puriﬁed following their expres-
sion in E. coli, were tested alongside wild-type LEDGF/
p75 to assess their ability to stimulate HIV-1 integrase
activity under reaction 1 conditions.
Experiments conducted with naked target DNA gener-
ated results in agreement with previous studies (27)
(Figure 3B). LEDGF
1–266 missing the IBD or the full-
length LEDGF
D366N missense mutant stimulated integra-
tion at  2% and 12% of the wild-type protein,
respectively, highlighting the central role of the LEDGF/
p75–integrase interaction in activating enzyme function
under these conditions (Figure 3B, panels 2 and 3; results
summarized in Figure 3A). Though the IBD is necessary
for stimulation, it alone is insuﬃcient (24,27) as evidenced
by the fact that the LEDGF
326–530 C-terminal fragment
containing the intact IBD failed to eﬀectively stimulate
integrase activity (Figure 3B, panel 5). Also in agreement
with previous ﬁndings, DNA binding was in large part
dispensable for activation, as full-length proteins altered
at the AT-hooks or AT-hooks and NLS (MutL4, MutL3,
MutL1) were reduced by 55% at most in their abilities to
stimulate integration (Figure 3A and B). The PWWP
domain was also not crucial for activation, since its
removal only resulted in an  40% decrease in function
(Figure 3B, panel 4). LEDGF
MutL8 lacking the PWWP
domain and furthermore mutated in the NLS/AT-hook
DNA-binding elements was likewise only about 2-fold
defective in its ability to stimulate integrase activity
(panel 10). We therefore conclude that LEDGF/p75’s
ability to stimulate integration into naked DNA depends
on its interaction with integrase as well as the PWWP
domain, NLS, AT-hooks and CR sequences that encom-
pass the N-terminal 325 residues of the protein.
Results obtained utilizing PNs were compared to those
observed using naked DNA (Figure 3A, right and C).
As anticipated, the integrase–LEDGF/p75 interaction was
central to stimulating integration into PNs. The NLS/
AT-hook mutants also behaved similarly, in that each of
these stimulated integrase activity similar to the wild-type
protein. A major diﬀerence was however observed when
the PWWP domain deletion mutants were assayed. The
LEDGF
93–530 mutant lacking the domain functioned at
 18% of the wild-type level when PNs were the
integration target, whereas its activity was reduced only
about 2-fold in stimulating integrase to function with
naked target DNA (compare panels 4 in Figure 3B and C;
P=1.1 10
 3 using Student’s t-test). More dramatically,
knocking out the AT-hooks and NLS reduced the
function of LEDGF
MutL8 to only  4% of wild type
under conditions where protein function was again
reduced only  2-fold from the wild type when naked
DNA served as the target (panels 10 in Figure 3B and C:
P=1.1 10
 10 using Student’s t-test). Experiments con-
ducted under higher protein concentrations revealed the
same overall trend. LEDGF
MutL8 was most active at
1.5mM (the highest concentration tested; data not shown),
but integration into PNs was still  5-fold reduced from
the suboptimal level of wild-type activity observed under
these conditions (Figure 2A). We therefore conclude that
LEDGF/p75 stimulation of HIV-1 integration into PNs
in vitro depends on its interaction with integrase as well as
the PWWP domain, with secondary contributions coming
from the NLS and AT-hooks that were for the most part
unnoticed unless assayed together with the PWWP
domain deletion (Figure 3C, compare panel 10 with
panels 7–9). It is noteworthy that these requirements are
nearly parallel to those obtained when LEDGF/p75
mutants were tested for their abilities to reconstitute
HIV-1 infection to cells severely depleted (23) or knocked
out (15) for the host factor. Mutants lacking the IBD
(15,23) or carrying the conservative D366N substitution
within the otherwise intact domain (15) failed to rescue
HIV-1 infection. Mutants lacking both the PWWP
domain and AT-hooks likewise failed to rescue infectivity
(15,23). The PWWP domain was moreover determined to
act as the dominant N-terminal determinant ex vivo:
expressing the LEDGF
93–530 PWWP domain deletion
mutant rescued  17% of HIV-1 function, whereas
expressing a full-length missense mutant carrying the
MulL3 AT-hook mutations fully restored HIV-1 infection
(15). We note that other host DNA-binding proteins like
HMGA (45,46), HMGB (45) and INI1 (47) have also been
Nucleic Acids Research, 2008, Vol. 36, No. 4 1241shown to stimulate HIV-1 integration in in vitro assays.
However unlike LEDGF/p75, ex vivo infections of
genetically null HMGA (48) or INI1 (49) cells have
failed to reveal a role for either of these factors in
integration under physiologically relevant conditions.
Characterization of LEDGF/p75 regionsimportant
forDNA and chromatinbinding in vitro
The PWWP domain in large part mediates LEDGF/p75
binding to chromatin in live cells (27,28), but the
mechanism underlying this interaction is unknown.
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right; values <20% are boxed. (B) Relative levels of HIV-1 integration in the presence of the noted LEDGF/p75 variant and naked target DNA
template. The initial value is the level of integrase activity in the absence of added LEDGF/p75, with the following sets conducted in the presence of
150 or 500nM protein (indicated by the triangle). Error bars are the variation obtained from duplicate PCRs of integration assays performed in
triplicate. The dashed horizontal line denotes 20% of the level of activity obtained in the presence of 500nM of wild-type LEDGF/p75. The vertical
arrows highlight those constructs that failed to attain this level of activity. (C) Same as in panel B, except that PNs were used in place of naked DNA.
1242 Nucleic Acids Research, 2008, Vol. 36, No. 4Unclear is whether the PWWP domain principally
interacts with DNA or a protein component(s) of
chromatin: one study failed to detect signiﬁcant binding
between the isolated domain and DNA in vitro (27),
whereas a separate study indicated that a 58 amino acid
residue stretch within the domain contributed to DNA
binding (29). The results of the previous experiments
revealed a signiﬁcant role for the PWWP domain in
LEDGF/p75-dependent activation of integration into
PNs, but not naked DNA. To ascertain if the PWWP
domain mediated binding to nucleosomes, an interaction
assay was designed to simultaneously monitor LEDGF/
p75 binding to free DNA versus nucleosomes. For this,
full-length or truncated LEDGF/p75 GST fusion proteins
(Figure 4A) pre-bound to glutathione-sepharose beads
were incubated with radiolabeled DNA or assembled
nucleosomes. Bound DNA was detected following depro-
teinization, gel electrophoresis and phosporImager analy-
sis. Bound nucleoprotein complexes were analyzed for
core histone H3 content by western blotting or for DNA
content after deproteinization and agarose gel
electrophoresis.
Initial experiments were performed at 50mM NaCl,
which corresponds to the salt concentration present in
the enzymatic reactions. Under these conditions, the
C-terminal deletion mutant LEDGF
1-325 bound the
5S-G5E4 restriction fragment as eﬃciently as wild-type
LEDGF
1–530 and the C-terminal domain fragment
LEDGF
326–530 failed to detectably bind DNA (Figure 4B,
lanes 2–4). Consistent with our earlier report (27), the
internal LEDGF
93–471 fragment also bound DNA as
eﬃciently as full-length LEDGF/p75 (Figure 4B, lane 6).
Truncation of this fragment to remove the tripartite
NLS/AT-hook element revealed residual activity for
LEDGF
226–471 that was lost upon further N-terminal
truncation to residue 326 (Figure 4B, lanes 7 and 8).
These results are fully consistent with the notion that the
NLS/AT-hook elements confer the majority of DNA-
binding activity under these conditions, with minor
contributions from sequences that lie within ﬂanking
CR3 (Figure 4A) and the PWWP domain (see below).
Strikingly similar results were obtained using PNs
instead of free 5S-G5E4 DNA, as the regions of the
protein that mediated PN capture were coincident to those
that mediated DNA binding (Figure 4B, compare lanes
10–18 with lanes 1–9). Because cell-based assays have
revealed a role for the PWWP in chromatin binding
(27,28), we considered that LEDGF/p75 might indirectly
capture nucleosomal complexes under these conditions via
binding to exposed linker DNA sequences present within
the PN template. Thus, to constrict the analysis to
nucleosome-speciﬁc binding, the pull-down experiment
was repeated using MNs, which lack linker DNA
sequences. The MN template was assembled on a 157bp
TPT fragment containing two GT phasing sequences (50)
that uniquely position the DNA around the histone
octamer (32) (Figure 1D). As expected from the results
of the previous experiments, LEDGF
93–471 bound to the
157bp naked DNA template as eﬃciently as wild-type
LEDGF/p75 (Figure 4C, compare lane 6 with lane 2).
LEDGF
226–471 again revealed residual binding to naked
DNA (Figure 4C, lane 7). As LEDGF
93–471 bound MNs
as eﬃciently as LEDGF
1–471 and the full-length wild-type
protein (Figure 4C, lanes 11, 14 and 15), the level of salt in
the binding assays was altered to ascertain eﬀects of
increasing ionic concentration on the protein–DNA and
protein–protein interactions. The residual binding of
LEDGF
226–471 to naked DNA (Figure 4D and E, lanes
4, 14 and 24) and both chromatin templates (MN and PN;
lanes 9, 19 and 29) was very sensitive to increasing salt, as
expected since the CR3 sequences within LEDGF
226–471
are likely to mediate electrostatic interactions with DNA
and nucleosomes (28). Elevated levels of salt importantly
unveiled a preferential role for the PWWP domain in
binding to nucleosomes as compared to naked DNA.
At 150mM NaCl, LEDGF
93–471 lacking the domain
bound-free TPT DNA  70% as eﬃciently as wild-type
LEDGF
1–530 (data not shown) and LEDGF
1–471
(Figure 4D, lanes 22 and 23) whereas MN capture was
reduced more than 3-fold as compared to the control
proteins (Figure 4D, lanes 27, 28, and data not shown).
This level of salt however failed to reveal a role for the
PWWP domain in PN binding (Figure 4E, compare lanes
7 and 8 with lanes 2 and 3). A higher concentration of salt
(250mM NaCl) did reveal a role for the PWWP domain in
PN capture (Figure 4E, lanes 27 and 28) although this
eﬀect seemed primarily attributable to a loss in DNA
binding (lanes 22 and 23). We therefore conclude that the
absence of DNA linkers in the MN templates emphasized
the requirement of the PWWP domain in the interaction
between LEDGF/p75 and nucleosomes.
These data suggested that the PWWP domain likely
provides a direct link between LEDGF/p75 and nucleo-
somes during PN-dependent activation of HIV-1 integra-
tion. Isotonic (150mM) NaCl nonetheless failed to reveal
a diﬀerence in LEDGF
1–471 versus LEDGF
93–471 binding
to free DNA versus PN templates. To directly test a role
for the PWWP domain in PN binding under physiological
salt conditions, a GST-PWWP domain fusion protein
containing the N-terminal 100 residues of LEDGF/p75
was puriﬁed and tested in the pull-down assay. GST-
PWWP displayed some aﬃnity for naked DNA, however,
unlike the case for the GST-LEDGF
93–471 deletion mutant
(Figure 4E, lane 13), this interaction was very sensitive to
salt concentration (Figure 4F, lanes 1–5). In stark
contrast, PN binding by GST-PWWP was nearly as
eﬃcient at 150mM and 50mM NaCl (Figure 4F, compare
lane 8 with lane 6; quantiﬁcation indicated by vertical
arrow in rightward panel). We therefore conclude that the
PWWP domain possesses aﬃnity for binding to PNs at
physiologic NaCl concentration under these conditions.
We have however not addressed whether the PWWP
domain might interact directly with a core histone protein
or other chromatin factor that becomes part of our
reconstituted nucleosomal templates.
In conclusion, we have determined that LEDGF/p75-
dependent stimulation of HIV-1 integrase activity in vitro
is in most cases favored by using chromatinized as
compared to naked target DNA acceptor templates
(Figure 2A). Stimulation of integration into either
template strictly depended on the LEDGF/p75–integrase
interaction. Three lines of experimentation however
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Figure 4. Characterization of the DNA and nucleosome-binding domains of LEDGF/p75. (A) Scheme of the 530 residue human LEDGFp75
protein, highlighting the PWWP domain, charged regions (CRs) 1–3, the NLS, AT-hooks and IBD (27,28). Residues retained in the GST fusion
proteins are indicated by bold lines. Relative levels of DNA binding at 50mM NaCl are summarized at the right. (B) Wild-type and mutant LEDGF/
p75 binding to 5S-G5E4 DNA (lanes 1–9) and PN templates (lanes 10–18). Puriﬁed GST was substituted for LEDGF/p75 in the reactions
(50mM NaCl) in lanes 1 and 10. Lanes 2 and 11 contained wild-type LEDGF
1–530; lanes 3 and 12, LEDGF
1–325; lanes 4 and 13, LEDGF
326–530;
lanes 5 and 14, LEDGF
1–471; lanes 6 and 15, LEDGF
93–471; lanes 7 and 16, LEDGF
226–471; lanes 8 and 17, LEDGF
326–471; lanes 9 and 18,
LEDGF
347–471. The lower panel on the right was developed using anti-histone H3 antibodies. (C) TPT DNA (lanes 1–9) and MN (lanes 10–18)
binding. The reactions in lanes 1–18 were identical to those in panel B except for the identity of the indicated DNA and nucleosome templates.
(D) Same as in panel C, except that binding of LEDGF mutants to TPT DNA (lanes 1–5, 11–15 and 21–25) or MNs (lanes 6–10, 16–20 and 26–30)
was performed at 50mM NaCl (lanes 1–10), 100mM NaCl (lanes 11–20) or 150mM NaCl (lanes 21–30). GST alone was analyzed in lanes 1, 6, 11,
16, 21 and 26. Lanes 2, 7, 12, 17, 22 and 27 contained LEDGF
1–471; lanes 3, 8, 13, 18, 23 and 28 harbored LEDGF
93–471; lanes 4, 9, 14, 19, 24 and 29
used LEDGF
226–471; lanes 5, 10, 15, 20, 25 and 30 used LEDGF
326–471.( E) Same as in panel D, except that binding assays were conducted using 5S-
G5E4 DNA (lanes 1–5, 11–15 and 21–25) or PNs (lanes 6–10, 16–20 and 26–30) in the presence of 150, 200 or 250mM NaCl, as indicated.
(F) Capture of free 5S-G5E4 DNA (lanes 1–5) or PN templates (lanes 6–10) by GST-LEDGF
1–100 at diﬀerent salt concentrations. The right panel
shows a plot of quantiﬁed radiolabeled DNA recovery (naked or assembled in PN) as a function of salt concentration; error bars represent the
variation obtained from four independent experiments.
1244 Nucleic Acids Research, 2008, Vol. 36, No. 4support the notion that the mechanism of stimulation
diﬀers when using naked DNA versus PNs. Among these
were diﬀerential responses to the concentration of
LEDGF/p75 (Figure 2A) and to the order by which
diﬀerent components were added into the reaction
mixtures (Figure 2B). Chromatinized templates were
furthermore critical to unveil the stimulatory requirements
of the PWWP domain and AT-hooks of LEDGF/p75,
which up until now were only detected in the context of
HIV-1-infected cells. Pull-down assays moreover indicated
the PWWP domain might preferentially interact with core
components of reconstituted human nucleosomes. We
therefore conclude that chromatinized templates aﬀord an
in vitro system that best recapitulates the role of LEDGF/
p75 in HIV-1 integration as it occurs in vivo.
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